Efficacy and safety of paclitide versus paclitaxel for locally advanced and/or metastatic breast cancer: an open-label, multi-center, phase IIb, randomized controlled trial.

Trial Profile

Efficacy and safety of paclitide versus paclitaxel for locally advanced and/or metastatic breast cancer: an open-label, multi-center, phase IIb, randomized controlled trial.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Paclitide (Primary) ; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date changed from 1 Jun 2011 to 30 Nov 2012 as reported by Chinese Clinical Trial Register record.
    • 03 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top